Additional Details
-
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Kelowna Respirology & Allergy ResearchKelowna BC. V1Y 3H5View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Dr. Georges-L.-Dumont University Hospital CentreMoncton NB. E1C 2Z3View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
QEII Health Sciences CentreHalifax NS. B3H 3A7View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
University of California San DiegoLa Jolla CA. 92093View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
University of North Carolina at Chapel HillChapel Hill NC. 27514View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Tufts Medical CenterBoston MA. 02111View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
University of MinnesotaMinneapolis MN. 55455View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
The Medical Research Group, Inc.Fresno CA. 93720View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
University of Cincinnati HealthCincinnati OH. 45219View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
National Jewish HealthDenver CO. 80206View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
University of RochesterRochester NY. 14627View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Advent HealthOrlando FL. 32803View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Tampa General Hospital Center of Research ExcellenceTampa FL. 33606View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Medical University of South CarolinaCharleston SC. 29425View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UCSFSan Francisco CA. 94143View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UC DavisSacramento CA. 95817View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Houston MethodistHouston TX. 77030View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Hartford HospitalHartford CT. 06102View Details -
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
UCLA WestwoodLos Angeles CA. 90095View Details